Since most breast cancer bone metastases generate osteolytic bone lesions, we expanded our analysis of the metastatic niche to include osteoblastic cells (CFP+ cells in Col2.3-CFP reporter mice backcrossed onto a BALB/c background). The gene discussed is CFP; the disease is breast carcinoma.